Suanfarma Biotech
4
655K
4
0.14
1
- Areas of investment
Summary
Suanfarma Biotech is the famous Corporate Investor, which was founded in 1993. The venture was found in Europe in Spain. The main office of represented Corporate Investor is situated in the Alcobendas.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Suanfarma Biotech, startups are often financed by SODENA. The meaningful sponsors for the fund in investment in the same round are Clave Mayor, SODENA, Caixa Capital Risc.
The fund is constantly included in less than 2 deals per year. This Suanfarma Biotech works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2008.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Biopharma. Among the most popular portfolio startups of the fund, we may highlight 3P Biopharmaceuticals. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.14
- Investments by industry
- Biotechnology (4)
- Medical (3)
- Health Diagnostics (1)
- Biopharma (1)
- Health Care (1) Show 3 more
- Investments by region
-
- Spain (4)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Group Appearance index
- 0.75
- Avg. company exit year
- 13
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.